Defining mechanisms through which neuropeptide Y drives hunger and body weight
Defining mechanisms through which neuropeptide Y drives hunger and body weight
批准号:
BB/V010557/1
负责人:
Jose Gonzalez
金额:
$56.73万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In recent decades obesity has become increasingly common around the world and this has led to significant and growing problems for health systems and societies globally. In terms of physical health, obesity increases the risk of heart disease, diabetes, cancer and associated complications. The main driver for obesity is eating more food than our bodies require, and the extra calories get stored as body fat. Thus, to be able to tackle obesity and its complications it is essential to understand how hunger and fullness are sensed in the brain. More than half a century ago, researchers discovered a part of the brain that is essential for controlling hunger, a region called the lateral hypothalamus. Despite this long-standing knowledge, it still is not known how this brain region fundamentally controls appetite and body weight. Thus far, the majority of attention has focused on brain chemicals made in this region called orexin-hypocretin and melanin concentrating hormone (MCH). However, what has not yet been investigated is a principal regulator of hunger called neuropeptide Y (NPY). This small protein made in several regions of our brain produces a profound increase in hunger, much greater than orexin-hypocretin or MCH. Historically, efforts have focussed on a subset of NPY, agouti-related protein and GABA co-expressing cells in another hypothalamic brain region, the arcuate nucleus. It has been subsequently revealed that NPY made in these cells is not the main driver of hunger. Thus, it is likely that NPY in other brain regions largely contributes to its vital effect on appetite. Of these, a group of NPY cells in the lateral hypothalamus (LHA(NPY)) is particularly interesting because these cells are able to detect changes in sugar (glucose) levels in their local environment. It is likely that this ability to detect glucose helps the brain evaluate whether we need food and react accordingly.In this project I will test whether NPY, a major hunger stimulator made in the key hunger brain region the LHA, is an important way that hunger and body weight are controlled. The project aims to answer these questions:(1) How are LHA(NPY) cells regulated? Previous research and pilot data provide compelling evidence that LHA(NPY) cells detect and respond to fluctuations in sugar. I will investigate how LHA(NPY) cells respond to nutrients and to different food cues, and how these signals directly shape the activity of LHA(NPY) cells.(2) Are LHA(NPY) cells able to drive food intake and promote obesity? There is evidence in humans and in animals that NPY is critical for appetite and body weight, but it is less clear what the particular contribution from LHA(NPY) cells is. To answer this question, I will experimentally activate LHA(NPY) cells and investigate if this leads to short term and/or long term increase in food intake, and whether LHA(NPY) overactivity leads to obesity.(3) Is it possible to prevent obesity by inactivating LHA(NPY) cells? Because NPY potently stimulates appetite, it is likely that obesity can be prevented by selectively inactivating the cells in the LHA that make this protein. Pilot studies indicate that this is indeed the case. Additional experiments will confirm and expand these initial studies to evaluate how effective is LHA(NPY) inactivation at preventing obesity.This project aims to discover how the brain controls the types of food that we choose to eat, how much we eat, and how that affects body weight. In discovering this, it will bring us closer to being able to find new medications to dampen our urge to over-eat and thus reduce the growing burden of obesity on our health systems and societies.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
REU Site: Interdisciplinary Research for Undergraduates in the Plant Sciences: Genomes,Phenomes and Landscapes
-
批准号:1950503
-
项目类别:Standard Grant
-
资助金额:$33.93万
-
财政年份:2021
-
负责人:Jose Gonzalez
-
依托单位:
MRI: Acquisistion of an Illumina NextSeq 500 to Support Life Science Research at South Dakota State University
-
批准号:1532189
-
项目类别:Standard Grant
-
资助金额:$34.38万
-
财政年份:2015
-
负责人:Jose Gonzalez
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
-
批准号:82371255
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹立
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
-
批准号:82372015
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:熊丽琴
-
依托单位: